Status: Not accepting new claims. Hologic reached a global settlement of the BioZorb cases in January 2026.

Titanium Breast Marker Lawsuit (BioZorb)
The BioZorb titanium breast marker, implanted in breast cancer patients to guide radiation therapy, is alleged to be linked to chronic pain, device migration, and serious complications requiring surgical removal.
See Claim StatusATTENTION: BIOZORB TITANIUM BREAST MARKER VICTIMS
Lawsuits allege Hologic failed to adequately warn breast cancer patients about the risks associated with the BioZorb device.
Not Accepting New Claims
Claim Status
Hologic reached a global settlement of the BioZorb cases in January 2026.
If you already filed a claim, contact the attorney or claims office handling it. You may still qualify for other active lawsuits.
See Active LawsuitsFREE CASE REVIEW
SEE IF YOU MAY QUALIFY
How do we help YOU?
Hologic marketed the BioZorb device to breast cancer patients as a dissolvable marker to guide radiation therapy — but the titanium clip framework does not dissolve, and thousands of patients were left with chronic pain, device migration, and the need for additional surgery. These patients deserve justice and full compensation.
How does filing a claim work?
- 1. Tell us what happened. Choose the product and answer a few questions.
- 2. Our intake team reviews your answers.
- 3. If it fits, an independent attorney or their team contacts you to explain your options.
- 4. You decide whether to move forward.
- Remember: the case review is free. Attorneys commonly work on contingency, and fee terms are set by the attorney.
BioZorb caused preventable harm to breast cancer survivors — Hologic must be held accountable.
The BioZorb Tissue Marker was implanted in breast cancer patients following lumpectomy to mark the tumor bed for radiation targeting. Despite being marketed as absorbable, the permanent titanium clips remain in the body indefinitely. Thousands of patients reported chronic breast pain, device migration, infection, and visible protrusion — with many requiring painful surgical removal. Lawsuits allege Hologic knew of these risks and failed to adequately warn patients and surgeons.
What Is the BioZorb Titanium Breast Marker Lawsuit?
The BioZorb lawsuit involves legal claims filed by breast cancer patients who received the BioZorb Tissue Marker — a device implanted after lumpectomy to guide radiation therapy — and subsequently suffered chronic pain, device migration, infection, or required surgical removal. Manufactured by Hologic, the BioZorb device consists of a spiral scaffold with six titanium clips that were represented as dissolving over time, but the titanium framework remains permanently in the body.
Plaintiffs allege that Hologic knew about the high rate of complications and failure to absorb, yet continued to market the device without adequate warnings to patients or surgeons. Cases are being actively filed across the United States.
Who Can File a BioZorb Lawsuit?
You may be eligible to file a BioZorb lawsuit if you or a loved one received the BioZorb Tissue Marker following breast cancer surgery and subsequently experienced chronic breast pain, device migration, infection, visible protrusion of the device, or required surgery to remove it. Patients who were not fully informed of the device's permanent titanium components or its known complication rates may have strong claims.
Did your BioZorb implant cause pain, migration, or require removal?
See Claim StatusComplications Alleged to Be Linked to the BioZorb Device
- Chronic breast pain — persistent pain at the implant site long after surgery
- Device migration — the titanium clips shifting from their original position
- Infection and abscess — requiring antibiotics or additional surgical treatment
- Tissue hardening (fibrosis) — scar tissue forming around the device
- Skin erosion — device protruding through or breaking down the overlying skin
- Nerve damage — numbness, tingling, or shooting pain in the breast or chest area
- Surgical removal — requiring an additional procedure to extract the titanium framework
BioZorb Lawsuit Status & Compensation
BioZorb lawsuits are being filed across the United States, with plaintiffs alleging product liability, negligence, and failure to warn against Hologic. Attorneys are actively accepting new clients. Cases assert that Hologic misrepresented the device as absorbable while knowing the titanium clip framework would remain permanently in the body.
Compensation may include medical expenses for treatment and surgical removal, lost wages during recovery, pain and suffering, emotional distress, and permanent scarring or disfigurement damages. There is no upfront cost — attorneys handle these cases on a contingency fee basis, meaning you only pay if you receive a settlement.
Last reviewed: · Lawsuit descriptions summarize allegations made in court filings, not proven facts.
